Quantitative Analysis News and Research

RSS

Vutara 352 super-resolution fluorescence microscope introduced by Bruker

At the 2015 Cell Biology ASCB Annual Meeting, Bruker today announced the release of the first quantitative super-resolution microscope, the Vutara™ 352.

From Bruker BioSpin - NMR, EPR and Imaging 15 Dec 2015

Coordinated health care not helping people with mental health conditions

People who are diagnosed with mental health conditions did not see improvements in coordination and quality of care as hoped but did not experience large cuts in access as some had feared under an early alternative payment model designed to encourage coordinated health care, according to a team led by researchers from Harvard Medical School and Johns Hopkins Bloomberg School of Public Health.

8 Dec 2015

Scientists calculate precise measurements of heritability in nine pediatric-onset autoimmune diseases

Scientists have calculated more precise measurements of heritability--the influence of underlying genes--in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.

9 Oct 2015

Next generation quantitative live-cell microscope released by Bruker

Bruker today announced the release of the Opterra II™ Multipoint Scanning Confocal Microscope, which represents the next generation of quantitative live-cell microscopes.

From Bruker 11 Aug 2015

The future of MPI: an interview with Dr Nikolaos Panagiotopoulos, University Hospital Schleswig Holsten

I’m Dr Panagiotopoulos and I am a resident at the University Hospital of Schleswig-Holstein. I work in the Radiological and Nuclear Medicine Department, at the Lübeck campus.

From Bruker BioSpin - NMR, EPR and Imaging 5 Jul 2015

Proteomics research market estimated to reach $1.6 billion this year

Pharmaceutical companies and diagnostics companies spend billions developing new drugs and tests, and this is translating into a sizeable market for the instruments that can assist them. This according to Kalorama Information, a healthcare market research publisher. Kalorama Information said instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and the validation of biomarkers, are in demand.

29 May 2015

Study explores outcomes of thyroid surgery in professional singers

A diagnosis of thyroid cancer can be devastating to professional singers, because surgical removal of the thyroid commonly causes voice changes. Massachusetts Eye and Ear surgeons developed a neural monitoring system to be used intraoperatively to improve outcomes.

25 Mar 2015

TRMC expands use of capnography to monitor patients during moderate sedation

Tillamook Regional Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients during moderate sedation. Sedation is commonly used during procedures such as colonoscopies and in some instances can suppress breathing.

12 Mar 2015

Choosing the best way to verify the quality and quantity of Chromatin Immunoprecipitation DNA

Porvair Sciences has published a new guide to help laboratories choose the best way to verify the quality and quantity of their Chromatin Immunoprecipitation (ChIP) DNA.

From Chromatrap® - Porvair Sciences Ltd 25 Nov 2014

PHI collaborates with Northeastern University for establishing novel cell analysis applications

Phase Holographic Imaging (PHI) today announces a collaboration agreement with Northeastern University of Boston.

8 Sep 2014

Special issue looks at how researchers use bioinformatics to understand plant form

As technology advances, science has become increasingly about data-how to gather it, organize it, and analyze it.

30 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Advanced Cell Diagnostics’ in situ hybridization technology reaches two major milestones

Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology have been published, and with the significant increase in use of RNAscope, ACD has now built a library of over 4000 target probes for numerous species. Probes are designed to order in under two weeks, and in just six months the library has grown by over 1500, reflecting the wide interest in ACD’s breakthrough technology.

From Advanced Cell Diagnostics 15 Jul 2014

Most NHL players peak by 29

A new University of British Columbia study identifies when the clock runs out on an NHL player's peak performance, giving team executives insight into how best to build a roster.

15 May 2014

InDevR, Applied Microarrays partner to offer complete system solution for multiplexed assays

InDevR Inc., a Boulder-based biotechnology company, and Applied Microarrays, Inc., a Tempe-based contract microarray manufacturer have partnered to deliver a complete system solution for multiplexed assays. The platform includes custom protein and DNA arrays, reagents and protocols, a fluorescent scanner for slides or plates (Vidia) and a colorimetric scanner for lower throughput applications (ampliPHOX).

30 Apr 2014

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

From Sheffield Hallam University 29 Apr 2014

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

25 Apr 2014

Princeton professor receives Agilent Thought Leader Award to research on cellular metabolism activity

Agilent Technologies Inc. today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University's Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, has received an Agilent Thought Leader Award to support his work on quantitative analysis of cellular metabolism.

18 Apr 2014

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

MR cardiac exams are faster and more accurate with new tools from Toshiba America Medical Systems, Inc. CardioLine, now available on the Vantage Titan™ 1.5T and 3T MR systems, improves workflow and standardizes exams to meet the pressures of today's cardiology market.

29 Mar 2014

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.

19 Mar 2014